Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC
Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC
Not yet recruiting · NCT06934590 · Registry updated 2025-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate Safety and Tolerability of RX001 in Patients With KRAS Mutant Advanced NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 1 | 2025-04-23 | NCT06934590 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GeneCraft Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Konkuk University Medical Center | Seoul | South Korea | 29 |